Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump in Q4 profit. While the stock did decline slightly this week, pharma analysts are positive on the stock as the company has shown growth across key therapies. The biggest reason for optimism is Sun Pharma’s global specialty business, which exceeded USD1 billion in sales in
Related Posts
Cipla Stock: Cipla is banking on US growth and strong India business. But are the positives priced in its stock?
Cipla has become one of the favourite large-cap stocks of investors of late. Since the Covid-19 outbreak in March 2020,…
Ayurvedic: Ayurvedic herbs are unsafe; Homeopathy is a classical quackery: Liverdoc Cyriac Abby Philips
Cyriac Abby Philips, popular on X as Liverdoc, has waged an unyielding battle against alternative medicines like Ayurveda, Homeopathy, Unani…
us shark tank: Selling cut-price generics, Mark Cuban is shaking up US pharma. Can Indian drug makers benefit?
Getty Images Mark Cuban. Synopsis Most of the large Indian pharma companies earn a big chunk of their revenue by…